Markets

Market

News Details

(02/12/2025 13:17)

SPARC wins U.S. Court Ruling on Priority Review Voucher for Sezaby

Sun Pharma Advanced Research Company Ltd (SPARC) announced that the U.S. District Court for the District of Columbia has granted summary judgment in its favour regarding the issuance of a Priority Review Voucher (PRV) linked to the approval of Sezaby.

The court ruled that the U.S. FDA’s decision to withhold the PRV was unlawful, stating that “no drug product containing phenobarbital sodium was ‘previously approved’ as that term is used in the statute.” The ruling allows a 60-day window for appeal.

Commenting on the development, SPARC CEO Anil Raghavan said the decision reaffirms the company’s long-standing position on the matter.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remain in investor's account.